Neuropsychological correlates of the P300 in patients with Alzheimer's disease

https://doi.org/10.1016/j.pnpbp.2012.08.009Get rights and content

Abstract

Objectives

The P300 is a useful psychophysiological index that reflects cognitive functions; however, the relationship between P300 indices and neuropsychological tests in Alzheimer's disease (AD) patients is unclear.

Methods

Thirty-one AD patients and 31 elderly normal control (NC) subjects were recruited. Age and education level were matched between the two groups. The relationship between the P300 and the Korean version of the Consortium to Establish a Registry for Alzheimer's disease (CERAD-K) assessment packet (including 11 neuropsychological tests) was examined in AD patients.

Results

Compared to the NC subjects, the AD patients exhibited significantly decreased P300 amplitudes; however, there was no significant difference between the two groups in terms of P300 latency. After a permutation-based correction for multiple tests, P300 amplitudes at the Cz and Pz electrodes were significantly correlated with performance on the word list recognition, constructional praxis, and word fluency neuropsychological tests in the AD patients. Additionally, P300 latencies at the Pz and C6 electrodes were also significantly correlated with performance on the Mini-Mental State Examination, CERAD-K version (MMSE-K), and Trail Making Test part A (TMT-A) neuropsychological tests in the AD patients.

Conclusions

The results suggest that the P300 is responsive to the deterioration of language, memory, and executive functions observed in AD patients. Although there was no significant difference between the AD patients and NC subjects in the P300 latency, P300 latency has been shown to reflect impaired global cognition and attention deficits associated with AD. Our results suggest that P300 indices could be used as biological markers that indicate impaired neuropsychological functions in AD patients.

Highlights

► The P300 amplitude has reduced in AD patients. ► The P300 amplitude reflects executive, language, and memory function in AD patients. ► P300 latency reflects global cognition and attention deficit in AD patients. ► The P300 indices could be used as a biological marker in AD patients.

Introduction

Alzheimer disease (AD), one of the most common causes of mental deterioration in the elderly, is a progressive neurodegenerative disorder that is characterized by cognitive and behavioral dysfunction. This disease has a slow onset and gradual progression. Early treatment is needed for better treatment outcome; therefore, an early diagnosis of the condition is very important. Although the biological methods used to diagnose and evaluate AD patients are still very rudimentary (Kim et al., 2012), the P300 component of event-related potentials (ERPs) has been used to study dementia and aging (Polich, 2007). There are some distinguishable ERP components in the time range of the P3 wave, specifically a frontally maximal P3a component and a parietally maximal P3b component. The P3a component is characterized by an infrequent, distinct tone presented in a series of frequent tones without a task. The P3b component is a task-relevant potential elicited during target stimulus processing. When ERP researchers refer to the P3 component, they usually mean the P3b component (Luck, 2005, Polich, 2007). The P300 component is easy to observe and reflects both attention and working memory processing (Polich, 2007). Polich et al. reported that the amplitude of P300 was smaller and that the peak latency was longer in AD patients compared to control subjects (Polich et al., 1990). The P300 has been revealed as a sensitive tool to detect the progress of AD in the initial stage (Polich and Corey-Bloom, 2005), and similar findings were found in minimal cognitive impairment (MCI) patients (Frodl et al., 2002, Golob et al., 2002, Golob et al., 2007).

Lai et al. (2010) investigated the P300 of probable AD patients, MCI patients, and normal controls in a 1-year prospective study. The cognitive abilities screening instrument (CASI) test was used to screen the patients (Cullen et al., 2007). In this study, the P300 amplitude reduction and CASI score changes failed to reach statistical significance between the baseline and the follow-up in probable AD and MCI patients; however, the P300 latencies were significantly more delayed in the follow-up (Lai et al., 2010). In general, the P300 amplitude and latency have been revealed as sensitive markers that indicate the progress of cognitive dysfunction in AD patients (Ball et al., 1989, Polich et al., 1986).

The diagnosis of AD is heavily dependent on the neuropsychological test scores of suspected AD subjects. There are relatively few studies, however, that have systematically investigated the relationship between neuropsychological tests and P300 parameters. A larger P300 amplitude has been related to better short- (Verleger, 1988) and long-term memory function (Johnson et al., 1985). Additionally, significant positive correlations were observed between the P300 amplitude and neuropsychological tests, such as verbal IQ, the Wechsler Memory Scale (Lee et al., 1994), digit span (Fjell and Walhovd, 2001), and the Trail Making Test part B (TMT-B), in healthy subjects (Lee et al., 1994) and obsessive–compulsive disorder patients (Kim et al., 2003). In sum, the P300 amplitude has been shown to be highly correlated with neuropsychological test scores, such as the TMT-B, the Wechsler Memory Scale, and digit span, in patients with several neuropsychiatric illnesses and in healthy controls.

The P300 latency indicates the stimulus classification speed (Katada et al., 2003) and the increased cognitive load (Reza et al., 2006), but it is not generally related to the response selection processes (McCarthy and Donchin, 1981, Pfefferbaum et al., 1986). The P300 latency indicates how long it takes to process information before making a response; therefore, it has often been considered a sensitive temporal index of the neural activity underlying the processes of attention allocation and immediate memory (Polich, 2007). The P300 latency increases as cognitive capability decreases in AD patients (Lai et al., 2010) and is also significantly correlated with neuropsychological tests, such as the TMT-B (Kim et al., 2003), the Stroop task (Kindermann et al., 2000), the Wechsler Adult Intelligence Scale (Liu et al., 2007), and verbal fluency (Souza et al., 1995). Thus, the P300 latency may play an important role in indicating the cognitive dysfunction associated with AD (Katada et al., 2003). To date, no studies have directly evaluated the relationship between the P300 indices and multiple diagnostic neuropsychological tests in AD patients.

Various neuropsychological tests have been used widely for the diagnosis of AD in clinical practices. Recently, the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) also developed standardized clinical and neuropsychological assessment batteries to evaluate patients with AD. Although it is important to make a psychophysiological validation of each neuropsychological test in the CERAD package, it has not been tested in a clinical sample yet. If there is a significant relationship between the neuropsychological tests of CERAD and the P300 parameters, it will provide clinically valuable information for diagnosing dementia. In this study, we hypothesized that changes in the P300 (i.e., reduced amplitude and delayed latencies) would be correlated with the neuropsychological tests of the CERAD in AD patients, thereby providing evidence that the P300 could be used as a biological marker of the cognitive dysfunction associated with AD. In the present study, we have correlated the P300 with the CERAD-K (the Korean version) neuropsychological tests in patients with AD and age- and education-matched normal controls to evaluate the clinical implication of the P300 in AD patients. If significant correlations exist, we may be able to monitor the progress of AD or the effects of therapeutic interventions in AD patients by measuring the P300.

Section snippets

Participants

Patients with AD and healthy controls were recruited from the Psychiatry Department of Inje University, Ilsan Paik Hospital, Korea. The AD patients were diagnosed as probable AD by the structured diagnostic evaluation using the CERAD-K (Lee et al., 2002) on the basis of the National Institute of Neurological and Communication Disorders and the Stroke-Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria (McKhann et al., 1984). The Clinical Dementia Rating Scale (CDR) (

Demographic data and neuropsychological test results

Thirty-one AD patients and 31 NC were recruited. Age (AD: 76.45 ± 5.57 years, NC: 75.84 ± 4.74 years) and education level (AD: 5.0 ± 5.36 years, NC: 5.13 ± 3.72) did not differ significantly between the AD patients and the NC subjects. The AD patients were classified as having mild AD (N = 18, CDR score: 0.5 or 1), moderate AD (N = 9, CDR score: 2) or severe AD (N = 4, CDR score: ≥ 3). The mean scores of all subset tests of the CERAD-K (verbal fluency, K-BNT, MMSE-KC, SBT-K, word list memory, constructional

Discussion

The P300 amplitude was significantly decreased in the AD patients compared to the NC subjects, as observed in almost all of the electrodes. Our results are consistent with previous studies that reported a decreased P300 amplitude in AD patients (Boller et al., 2002, Frodl et al., 2002, Yamaguchi et al., 2000). Ally et al. (2006) reported that the P300 amplitude was significantly decreased in AD patients compared to age- and gender-matched normal controls. Additionally, their biological children

Acknowledgements

This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (no. A08-4117-A22023-08N1-00010A).

References (73)

  • J.D. Henry et al.

    Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis

    Neuropsychologia

    (2004)
  • M. Houlihan et al.

    Intelligence and the effects of perceptual processing demands, task difficulty and processing speed on P300, reaction time and movement time

    Intelligence

    (1998)
  • M.S. Kim et al.

    Neuropsychological correlates of P300 abnormalities in patients with schizophrenia and obsessive-compulsive disorder

    Psychiatry Res

    (2003)
  • S.S. Kindermann et al.

    Executive functions and P300 latency in elderly depressed patients and control subjects

    Am J Geriatr Psychiatry

    (2000)
  • C.L. Lai et al.

    The role of event-related potentials in cognitive decline in Alzheimer's disease

    Clin Neurophysiol

    (2010)
  • A. Pfefferbaum et al.

    Apparent response incompatibility effects on P3 latency depend on the task

    Electroencephalogr Clin Neurophysiol

    (1986)
  • J. Polich

    Attention, probability, and task demands as determinants of P300 latency from auditory stimuli

    Electroencephalogr Clin Neurophysiol

    (1986)
  • J. Polich

    Updating P300: an integrative theory of P3a and P3b

    Clin Neurophysiol

    (2007)
  • J. Polich et al.

    P300 latency reflects the degree of cognitive decline in dementing illness

    Electroencephalogr Clin Neurophysiol

    (1986)
  • J. Polich et al.

    P300 assessment of early Alzheimer's disease

    Electroencephalogr Clin Neurophysiol

    (1990)
  • F. Reza et al.

    Correlations between neuropsychological test results and P300 latency during silent-count and button-press tasks in post-traumatic brain injury patients

    J Clin Neurosci

    (2006)
  • V.B. Souza et al.

    Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder

    Biol Psychiatry

    (1995)
  • J.A. van Deursen et al.

    Response speed, contingent negative variation and P300 in Alzheimer's disease and MCI

    Brain Cogn

    (2009)
  • E. Vandoolaeghe et al.

    Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude

    J Affect Disord

    (1998)
  • S. Yamaguchi et al.

    Event-related brain potentials in response to novel sounds in dementia

    Clin Neurophysiol

    (2000)
  • S.S. Ball et al.

    Longitudinal P300 latency changes in Alzheimer's disease

    J Gerontol

    (1989)
  • F. Boller et al.

    Processing emotional information in Alzheimer's disease: effects on memory performance and neurophysiological correlates

    Dement Geriatr Cogn Disord

    (2002)
  • W.S. Brown et al.

    Event-related potentials in psychiatry: differentiating depression and dementia in the elderly

    Bull Los Angeles Neurol Soc

    (1982)
  • P. Chen et al.

    Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study

    Arch Gen Psychiatry

    (2001)
  • G. Chetelat et al.

    Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?

    Neurology

    (2003)
  • B. Cullen et al.

    A review of screening tests for cognitive impairment

    J Neurol Neurosurg Psychiatry

    (2007)
  • E. Donchin et al.

    Is the P300 component a manifestation of context updating?

    Behav Brain Sci

    (1988)
  • F.H. Duffy et al.

    Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type

    Ann Neurol

    (1984)
  • S. Elmstahl et al.

    Quantitative EEG in elderly patients with Alzheimer's disease and healthy controls

    Dementia

    (1994)
  • A.M. Fjell et al.

    P300 and neuropsychological tests as measures of aging: scalp topography and cognitive changes

    Brain Topogr

    (2001)
  • T. Frodl et al.

    Value of event-related P300 subcomponents in the clinical diagnosis of mild cognitive impairment and Alzheimer's disease

    Psychophysiology

    (2002)
  • Cited by (0)

    View full text